Open Access

Emerging and re-emerging infectious diseases: challenges and opportunities for militaries

  • Zheng Jie Marc Ho1Email author,
  • Yi Fu Jeff Hwang1 and
  • Jian Ming Vernon Lee1
Military Medical Research20141:21

DOI: 10.1186/2054-9369-1-21

Received: 14 May 2014

Accepted: 7 August 2014

Published: 24 September 2014

Abstract

The communal nature of living and training environments, alongside suboptimal hygiene and stressors in the field, place military personnel at higher risk of contracting emerging infectious diseases. Some of these diseases spread quickly within ranks resulting in large outbreaks, and personnel deployed are also often immunologically naïve to otherwise uncommonly-encountered pathogens. Furthermore, the chance of weaponised biological agents being used in conventional warfare or otherwise remains a very real, albeit often veiled, threat. However, such challenges also provide opportunities for the advancement of preventive and therapeutic military medicine, some of which have been later adopted in civilian settings. Some of these include improved surveillance, new vaccines and drugs, better public health interventions and inter-agency co-operations. The legacy of successes in dealing with infectious diseases is a reminder of the importance in sustaining efforts aimed at ensuring a safer environment for both military and the community at large.

Keywords

Communicable diseases Emerging Infectious disease medicine Military personnel

Introduction

Emerging and re-emerging infectious diseases are threats that military organisations have to guard against, as they cause substantial impact to operations and training. These diseases may arise from within the military community, as spill-over from the surrounding civilian populace, or during military operations and deployments. Biological warfare and bioterrorism are additional possibilities that militaries need to be prepared for.

Since historical times, emerging infectious diseases have impacted militaries, from the Plague of Athens in 430 BC during the Peloponnesian War linked to the poisoning of water reservoirs by the Spartans [1], and the similar Antonine Plague in 166 AD brought back by returning Roman soldiers from the Parthian War [2, 3]. The Thirty Years War from 1618 to 1648 also saw the devastating effects of Typhus (alongside Plague and accompanying starvation) which resulted in 10 million deaths [4], overshadowing 350,000 combat deaths. The weaponisation of naturally occurring diseases, the threat wrought by travelling soldiers returning home with novel diseases, and the disproportionate impact of disease and non-battle injuries (DNBIs) are still relevant to militaries of today. In more recent times, there have been outbreaks reported among military personnel in both peacetime and field deployments. These include a peacetime Salmonella outbreak in a military establishment in India in 2011 due to possible contamination of food [5], the 2013 scabies outbreak among the Queen’s Guards in the United Kingdom after a military exercise in Germany [6], and travellers’ diarrhoea among U.S. military troops deployed during a training and humanitarian mission in El Salvador in 2011 [7].

Deployment of militaries to foreign grounds also exposes troops to local endemic diseases. A classic example of this is malaria. During World War II and the Vietnam War, 124,109 and 24,606 respective cases among U.S. military personnel deployed to the Southwest Pacific and Vietnam were reported [8, 9]. Such infectious diseases have been shown to impact militaries significantly, not only in mortality and morbidity, but also in operational readiness. Even training during peacetime is affected by disease outbreaks, sometimes resulting in the unexpected suspension of military operations [10].Unlike civilian settings, the military may acquire emerging and re-emerging infectious diseases from a myriad of origins and these often spread more readily, posing unique challenges to their prevention and control. At the same time, the frequency and extent of outbreaks in military settings provide opportunities to understand these diseases, and to develop new strategies (Figure 1). This review discusses some of the challenges militaries face from infectious diseases, as well as the societal benefits that militaries have brought to the world as these diseases are managed.
Figure 1

Challenges and opportunities of emerging and re-emerging infectious diseases in the military.

Challenges in the military environment

Ease of disease transmission within military settings

Many diseases, especially airborne, food and water borne, as well as vector borne diseases have been shown to spread readily in the military due to the close communal living and training quarters, operational constraints, and unique field hygiene conditions. Harsh environments, physical exertion and sleep deprivation, inadequate hygiene and sanitation, and psychological stress all result in physiological and immunological changes [11]. Although militaries comprise mostly young adults who are physically and mentally fitter, the above factors place them at unusually higher risks of infection.

As a result, there have been numerous reports of infectious disease outbreaks in military settings. These include, but are not limited to, gastroenteritis (particularly Norwalk-like/norovirus outbreaks) [1214], acute respiratory infections (including influenza) [1517] and conjunctivitis (particularly due to adenovirus) [1820]. One report documented that US military trainees staying in a 60 person barracks were more susceptible to contracting acute respiratory infections than those in 8 person rooms, and that the risk was higher during the first few weeks of training before declining to baseline [21]. Similarly, ease of transmission due to close living quarters resulted in an Influenza A(H1N1) pdm09 outbreak in a Swiss military boot camp in 2010 involving 105 of 750 recruits [16]. These incidences reflect the need for preventive measures to protect against future incidences.

Transmission between military and the community

Some outbreaks in military settings are linked to an increased incidence of disease in the local civilian population. Although the extent of interactions between military and civilian elements vary across militaries, some mixing is inevitable either during transit of personnel from one setting to another, or through socio-civic duties such as disaster relief or community programs.

Amongst the many examples, a Hepatitis A outbreak from 1976 to 1977 in a U.S. military was linked to a nearby childcare facility [22], and concurrent civilian and military outbreaks of Human Adenovirus type 14 in Texas and Oregon in 2007 had possible civilian epidemiological links [23]. There were also reports of concurrent outbreaks of disease in both community and military settings during the outbreaks of enteroviral conjunctivitis in Singapore in 2005 [24] and mumps in Luxembourg in 2008 [25]. Significantly, both of these outbreaks occurred in small countries with military camps in close proximity to the population where increased opportunities for mixing occur.

Infection during deployments

Military deployments are commonplace in this age of globalisation and international co-operation, and this coincides with the fact that infectious diseases cross borders more frequently than ever before. Field and rural deployments place personnel at risk of new pathogens not normally encountered. As early as the First World War, the return of military forces from deployments to the trenches of Europe was suspected to have played a role in the rapid spread of the 1918/19 influenza pandemic [26]. More recently, 11 gastroenteritis outbreaks (10 caused by viruses) among British troops deployed overseas from 2002 to 2007 were documented [27]. Personnel returning to Australia from East Timor were also later diagnosed as having been infected with dengue from 1999 to 2000 [28], as did US servicemen infected with the malaria parasite in Iraq, Afghanistan and Korea from 2003 to 2005 [29]. Table 1 shows a selection of infectious diseases during more recent major military deployments and measures implemented (See also Figure 2). Many of these were ground breaking for their time, and provided evidence for their routine use today.
Table 1

Infectious diseases during military deployments and measures implemented

Operation

Year

Infectious diseases

Measures implemented

American Civil War

1861 to 1865

Malaria [30]

Use of Quinine

World War I

1914 to 1918

1918 Influenza [31]

Improvements in respiratory hygiene and isolation

Trench Foot [32]

Footwear modifications

Foot protection (grease, borated talc and camphor)

Measures to improve trench and boot drainage

Tetanus [33]

Prophylactic Anti-Tetanus serum to wounded

World War II

1939 to 1945

Wound infections [34, 35]

Use of Dakin’s solution for antisepsis

Use of Sulfanilamide and Penicillin

Scrub Typhus [36]

Development of delousing strategies

Malaria [37]

Use of Atabrine

Lymphatic Filariasis [38]

 

Korean War

1950 to 1953

“Korean Haemorrhagic Fever” (Hanta virus) [39]

Improvement in environmental health measures

Vietnam War

1953 to 1975

Malaria and Dengue [40]

Mosquito nets and repellents, Antimalarials including Mefloquine - designed by army to counter Chloroquine resistance.

Bubonic Plague (Yersinia pestis) [41]

Flea insecticide and repellents

Immunisation with plague vaccines

Protective clothing and Rat proofed dwellings

Persian Gulf War

1990 to 1991

Preparedness against Biological Warfare [42]

Anthrax, Botulinum, Meningococcus vaccines and Hepatitis A immunoglobulins

Operation Restore Hope

1993

Malaria [43]

Use of Mefloquine and Doxycycline

Operation Enduring

2001 to 2011

Leishmaniasis [44]

Genus specific probe for diagnosis

Freedom, Operation IraqiFreedom, Operation New

  

Treatment modalities under investigational new drug protocols

Dawn

  

Better shelters and insect repellents

  

Malaria [45]

Use of rapid diagnostic assays and Tafenoquine

  

Norovirus and Shigella [4648]

Use of rapid diagnostic assays

Segregation and enforcement of hygiene

Multidrug Resistant Wound infections and Nosocomial Transmission (especially Acinetobacter baumanii) [49]

Improvements in infection control practices, antibiotic restriction policies

Admission surveillance cultures of wounded soldiers and contact isolation

   

Need for new antibiotics targeting resistant Gram negative bacteria

Figure 2

Selected infectious diseases during military deployments [[1]-[4],[7]-[9],[15],[26],[28]-[30],[39, 41],[44],[50]-[61]].

The French Armed Forces reported that from 1999 to 2009, the rate of food borne disease outbreaks was significantly higher in servicemen deployed overseas (2.4 outbreaks/100,000 in France vs. 26.7 outbreaks/100,000 overseas). These were attributed to a lack of hygiene in operations and the consumption of unsafe local food [62]. Likewise, more than one-half of the 865 infectious diarrhoeal outbreaks in the Israeli military from 1988 to 2002 were in field units [63]. Diseases also tend to spread more efficiently during deployments, as seen by the development of four outbreaks of Norwalk-like viruses on board US Navy aircraft carriers from 1992 to 1997 which were attributed to crowding [50].

Military personnel are often also involved in disaster management, where they interact with displaced populations, themselves at risk of infectious diseases [64]. Water storage or stagnant water around temporary dwellings promotes breeding of vectors, made worse by the absence or interruption of vector control programmes. Furthermore, local food and water safety is poorly enforced, as is the spread of respiratory pathogens when military personnel interact with the local population. Vaccinations, chemoprophylaxis and personal hygiene measures are therefore critical in ensuring force protection when militaries deploy to these areas.

Increasing deployment of military forces from developing countries

Even developing country militaries that may not possess sophisticated public health capabilities are able to utilise many of the low cost disease prevention measures aforementioned. Some of these forces also double-up as health services for civilians in remote areas, reporting surveillance data to local health authorities, and contributing to national infectious disease surveillance [26]. Militaries also provide surge capacity during natural or man-made disasters when civilian resources are overwhelmed. There has also been an increase in number of developing countries contributing troops for multinational operations [26], and common standards of disease control should be applied to multilateral forces for collective protection. This may entail the distribution of resources from higher-income countries.

Novel infectious agents

Novel infectious agents such as zoonotic transmission of avian influenza viruses and Middle East respiratory syndrome coronavirus (MERS-CoV) pose challenges in early detection and prevention strategies, including military personnel who reside in or are deployed to affected areas. Returning travellers from affected areas also pose a threat and are difficult to screen if they visit these areas during personal leave. The impact of novel agents is shown by the effect of the 2009 pandemic H1N1 influenza on militaries from overseas importation or through the surrounding general population, with subsequent rapid spread in the closed living environments [65]. In addition, Dual Use Research of Concern (DURC) raises issues with regards to biosafety and biosecurity, such as that which involves the creation of laboratory-modified H5N1 viruses capable of respiratory transmission [66].

Biological warfare and bioterrorism

Biological agents have been used as weapons of war as early as 600 B.C., when cadavers and animal carcasses were used to weaken the enemy [67]. Blankets from smallpox patients were distributed by the British to Native Americans in 1763, and experiments involving various pathogens (including anthrax and meningococcus) were conducted by the Japanese biological warfare research program during World War II, the latter leading to numerous deaths [68]. Furthermore, biological agents can be utilised through unconventional means. The intentional contamination of salad bars in Oregon with Salmonella Typhimurium by the Rajneeshee cult in 1984 [69], the failed attempts to disperse botulinum toxin by the Japanese cult Aum Shinrikyo at various sites in Japan in the 1990s [70], and release of anthrax through mailed letters and packages in the U.S. in 2001 [71] are constant reminders of the ever present yet often concealed threat.

The need to protect against bioterrorism has thus emerged as a priority for most militaries. As bioterrorism can occur from the use of simple naturally occurring diseases to the development or theft of dangerous pathogens, it is important for militaries to prepare for and protect themselves against these threats. This includes the development of good diagnostic facilities for routine infectious diseases detection that also have the capability for detection of novel and dangerous pathogens. Laboratories (both military and civilian) should thus ensure the veracity of biosafety and biosecurity practices to prevent the occurrence of accidents or deliberate releases. This requires collaborations at the international level to strengthen global biosafety and biosecurity initiatives, and investments in capacity building at the local level, especially in settings of lower-resources.

Opportunities for militaries

Amidst these challenges, there are also multiple opportunities afforded for advancements in the prevention and control against infectious diseases in military settings, and history has shown how military medicine has risen to previous challenges.

Surveillance programs

Cross border spread and the emergence of novel pathogens have placed surveillance programs, such as that of the French Military Influenza Surveillance System (MISS) and the U.S. Armed Forces Health Surveillance Centre Global Emerging Infectious Surveillance and Response System (AFHSC-GEIS), as centrepieces in the early detection and warning of infectious diseases for the prompt implementation of mitigation and control measures.

These surveillance systems are important for the global surveillance of infectious diseases. Through the US Naval Health Research Centre’s surveillance program, Influenza A(H1N1)pdm09 in two California children was first identified, leading to the promulgation of an alert by the Centers for Disease Control and Prevention (CDC) [72]. This subsequently led to notification of another outbreak among New York students who had travelled to Mexico, and thereafter the detection of the same pathogen in outbreaks in Mexico [72]. These represented sentinel events leading to global awareness of the rapidly evolving situation.

Influenza surveillance can also be found in other armed forces, including the French who have participated in national surveillance through MISS since 1997. Its main objectives are the early detection of influenza outbreaks and monitoring of circulating viral strains [73]. Compared with national estimates, the MISS estimated lower amplitudes of influenza outbreaks in the military from 2008 to 2012, with possible reasons including younger ages, healthier personnel and compulsory influenza vaccination. In the Italian military, diseases such as measles and varicella are notifiable under its surveillance program [74]. These results have been used to guide organisational vaccination policies. For example, after a tenfold increase in measles and fourfold increase in rubella from 1976–1980 to 1991–1995, mandatory MMR vaccination was instituted. Likewise, on noting that influenza was the foremost cause for febrile respiratory illnesses leading to substantial morbidity [75], the Singapore Armed Forces thereafter instituted annual influenza vaccination with significant success [76].

Military surveillance is often a component of wider population-wide protection measures, such as the Medical Surveillance System implemented in support of the United Nations Mission in Haiti [77]. The Peruvian Navy also developed an electronic disease surveillance to rapidly consolidate reportable diseases, thereby allowing earlier detection and control of disease outbreaks in the country. Finally, the Royal Thai Army instituted HIV screening on conscription, thereby serving as an indirect monitor of the national HIV situation [26, 78].

Public health interventions

Public health interventions are equally as important in the management of infectious diseases in the military. These include contact precautions such as the disinfection of common living surfaces and hand hygiene, and droplet and airborne protection including isolating ill individuals and basic respiratory hygiene education. Food and water hygiene is also important due to the large numbers of individuals sharing common food and water sources. Some of these are more easily enforced in the controlled environments of military bases. However, once in the field, they pose a unique challenge where inadequate hygiene and sanitisation are often lacking. Even so, through innovations such as ready-to-eat meals and a host of water purification methods, militaries attempt to reduce these risks.

Positive examples of successful public health measures include the early identification and isolation of patients during the 1918 influenza pandemic which lowered attack rates in closed settings [79], and enhanced public health measures put in place for critical operations units in the Singapore military during the Influenza A(H1N1)pdm09 pandemic (including symptom monitoring and segregation into smaller subgroups when working) resulting in lower seroconversion rates (17% vs. 44% for other units) [80]. Likewise, a study involving conjunctivitis outbreaks in a military camp showed that for each day to which control measures were delayed, the outbreak itself was extended by 0.82 days [81].

Health education also plays an important role amongst military personnel. This includes basic concepts such as disease recognition and prevention strategies, food hygiene and handwashing, respiratory hygiene, cleaning of common areas, and monitoring for disease symptoms. In addition, select personnel can be further trained in the use of personal protective equipment which range from simple gloves and masks during cleaning of soilages, to full suits against biological attacks.

vAnother area of interest is the use of public health measures for the prevention and containment of infection, especially regarding resistant bacteria in the combat wounded [82]. Environmental studies in military hospitals indicate the presence of nosocomial transmission of multi-drug resistant pathogens and/or existing colonisation prior to injury [83]. These led to the step-up of education pre-deployment, standardisation and enhancement of infection control measures, improved electronic support, and admission screening for resistant bacteria colonisation [49]. In a separate study, the conduct of a 5-day infection control course also showed a 21% improvement in knowledge [84].

Further epidemiological, public health and translational research provide opportunities for future advancements and better interventions to prevent further spread and quick containment of infectious diseases.

Vaccination

Since the time George Washington ordered the Continental army recruits to be vaccinated with smallpox vaccines in 1777 in response to outbreaks of variola, vaccination has evolved to become an integral part of troop protection against infections [85]. The military has also contributed to the development of many of these vaccines. For instance, the first typhoid vaccine produced for national supply was by the US Army Medical School in 1909, based on British and German production methods. The first inactivated influenza and adenovirus vaccines [86] were also developed by the US military, becoming the first iterations of the vaccines used today. Furthermore, military sponsored research contributed to the eventual licensure of ten vaccines from 1945 to 1955 [87]. Table 2 summarises the role to which militaries have played in the development of vaccines.
Table 2

Vaccinations and military contributions[8589]

Vaccine

Year initiated

Military role

Smallpox

1777

Used by the Continental Army in 1777; Used by Prussian Army during the Franco-Prussian War in 1870

Yellow fever

1900

Demonstration of etiological agent and vector

Typhoid fever

1909

British Army used early forms during the Anglo-Boer War; US Military developed killed typhoid vaccine for US Army and Navy personnel

Tetanus

1940

Used by the US Army and Navy from 1940; Used by the Luftwaffe in World War II

Cholera

1940, 1980s

Injectable whole cell vaccines given to alert US Military Units until 1973

Hepatitis A

1945, 1985

US Military developed immunoglobulins and used in Korea and Vietnam in the 1960s; US Military supported safety, immunogenicity and efficacy studies

Pneumococcus

1945

US Military tested first multivalent polysaccharide vaccine

Diphtheria

1950s

US Military sponsored reduced dose formulation

Anthrax

1950s

Early anthrax vaccines were developed by Dr George Wright of the U.S. Chemical Corps and his colleagues, and were licensed in 1970.

Adenovirus

1952-1969

US Military developed killed bivalent and oral attenuated vaccine

Influenza

1957

US Military developed first iterations of influenza vaccines and conducted trials among US service members

Japanese Encephalitis

1950s, 1980s

US Military performed vaccination efforts in World War II and later supported inactivated vaccine studies

Plague

1960s

US personnel in Vietnam and Southern Vietnam soldiers vaccinated in the 1960s

Meningococcus

1968

US Military developed polysaccharide vaccine and supported clinical trials; Adopted by the Israeli Army in 1994

Rubella

1972

US Military developed technique for isolating virus used to develop the vaccine

Measles

1980

US Military provided funding for development of an attenuated vaccine

Vaccines continue to be under development through military sponsored studies. For instance, a Phase 3 trial on an oral adenovirus Type 4 and 7 vaccine was conducted among US Military recruits [90], with subsequent FDA approval in 2011. Continued research into vaccines against dengue, norovirus and HIV continue to be much anticipated by both military and non-military medical communities.

Militaries across the world have developed their own vaccination programs that are often more comprehensive than their respective civilian populations. The U.S. military has routine immunisation for infectious diseases influenza and adenovirus, and travel immunisation depending on exposure, such as variola vaccination for personnel in areas at higher risk for release of smallpox as a weapon [91]. This being so, a World Health Organisation Survey in the 1990s noted that while 90% of the 52 militaries surveyed claimed to have compulsory military immunisation schedules, compulsory vaccination for different infectious diseases varies across militaries from 19% for Measles, Mumps and Rubella to 87% for tetanus [92].

Chemoprophylaxis and treatment

The use of chemoprophylaxis and treatment against infections in the military continues to be an extensive field with opportunities for further exploration. During the American Civil War from 1861 to 1865, three studies on antiseptics (bromide, turpentine and nitric acid) showed reductions in mortality from hospital gangrene [93]. Almost 80 years later during the Second World War, the critical discovery of penicillin’s antibiotic effects propelled it to become second highest priority (behind the atomic bomb) by the U.S. War Production Board [94]. Its use has often been cited as pivotal to success of the Allied Forces [95].

Apart from antibiotics, military medicine has also helmed developments and innovations in the use of anti-parasitic and anti-viral chemoprophylaxis. The anti-malarial drug mefloquine was developed by the Walter Reed Army Institute in the 1960s, in collaboration with the World Health Organisation and Hoffman-LaRoche [96]. Further studies also showed synergism between atovaquone and proguanil, with subsequent co-administration trials conducted at various sites by military-associated laboratories in Kenya, Brazil and Indonesia. The Influenza A(H1N1)pdm09 pandemic also saw the effective use of oseltamivir ring prophylaxis in the Singapore Military in localised outbreaks to bring about significant reductions in the reproductive number (the number of new cases attributable to the index case) from 1.91 to 0.11, with significantly reduced rates of infection [97].

Other drugs have been, or are being evaluated for possible benefits of chemoprophylaxis in the military setting. These include the successful use of rifaximin for the prevention of travellers’ diarrhoea among travellers and deployed military personnel [98], and dilute Dakin solution for angioinvasive fungal infection in the combat wounded [99].

Militaries around the world have also implemented chemoprophylaxis programs against specific threats. The U.S. military has guidelines for different infectious diseases including pre-exposure prophylaxis for malaria during deployments to affected areas and post-exposure prophylaxis for anthrax and meningococcus exposure [91]. The Republic of Korea Army instituted a malaria prophylaxis program in 1997, and no malaria deaths have been reported since [100]. In Singapore, malaria prophylaxis is routinely used for travel to malarious locations globally. At the same time, on Singapore’s Tekong Island which houses a military training facility, an integrated combination malaria eradication strategy since 2006 has negated the need for malaria prophylaxis [101].

Co-operation between militaries and Non-military organisations

Collaborations between different militaries, as well as between militaries and civilian organisations on various levels are important in the prevention and control of infectious disease, and are best performed before the onset of outbreaks or epidemics. On a national level, the interface between the Peruvian military and Royal Thai Army (described earlier) with their respective national health networks allowed for smoother sharing of valuable information, so as to formulate more appropriate responses and measures where necessary [78]. On a larger scale, international networks allow participating countries to pool resources, providing greater equity. For example, the AFHSC-GEIS network picked up 76 outbreaks in 53 countries from 2008 to 2009, and involved supporting civilian entities in 48% of outbreak investigations, including a number of WHO regional reference laboratories [102].

Civil-military collaborations also play an important role during humanitarian efforts. After the earthquake in Haiti in 2010, security established by the military allowed civilian medical personnel more ready access to patients, and also provided critical equipment and supplies [103]. The Oslo Guidelines, updated by United Nations in 2007, provides guidelines for international military aid in disaster relief operations- one key point being that military assets should only be utilised when there are no viable alternatives, and with due regard for the sovereignty and leading role of local authorities [104, 105].

Enhancing lab diagnostic capabilities

As early detection plays an important role in the mitigation of infectious diseases, militaries have a responsibility to enhance their laboratory capabilities for diagnosis. To maximise the use of resources, militaries should work together with civilian laboratories to strengthen national capabilities in the detection of novel infectious agents under International Health Regulations, exemplified by the early detection of Influenza A(H1N1)pdm09 by a U.S. military laboratory [72]. In addition, militaries sometimes require rapid diagnosis of common diseases especially during field deployments where full laboratory facilities may be unavailable. Enhancing laboratory capacity in militaries should therefore extend to improving capabilities in field and austere conditions where diseases are often encountered.

Conclusion

Although the ever-changing infectious diseases scene and harsh operational and training environment pose unique and sometimes seemingly daunting challenges to military organisations, it also presents many opportunities for scientific advancements in the areas of prevention, mitigation and control. From surveillance to treatment and public health measures, the field of infectious diseases in the military has, more than ever before, many puzzles waiting to be solved. Military healthcare providers and administrators involved in this worthwhile endeavour should also be encouraged that the work they do goes beyond accruing direct benefits for militaries, often flowing to the greater community at large. As such, continued investment in military surveillance, research and management of infectious diseases is important to ensure that the world we live in is safer from the threat of diseases.

Authors’ information

All authors are from the Biodefence Centre, Headquarters of the Medical Corps, Singapore Armed Forces. LJM (MBBS, PhD, MPH, MBA) is Head of the Centre, Associate Professor at Saw Swee Hock School of Public Health, National University of Singapore, and Visiting Consultant at the Ministry of Health, Singapore and Communicable Disease Centre, Singapore.

Declarations

Authors’ Affiliations

(1)
Biodefence Centre, Headquarters of the Medical Corps, Singapore Armed Forces

References

  1. Papagrigorakis MJ, Synodinos PN, Stathi A, Skevaki CL, Zachariadou L: The plague of Athens: an ancient act of bioterrorism?. Biosecur Bioterror. 2013, 11 (3): 228-229. 10.1089/bsp.2013.0057.PubMedGoogle Scholar
  2. Fears JR: The plague under Marcus Aurelius and the decline and fall of the Roman Empire. Infect Dis Clin North Am. 2004, 18 (1): 65-77. 10.1016/S0891-5520(03)00089-8.PubMedGoogle Scholar
  3. Sabbatani S, Fiorino S: The antonine plague and the decline of the Roman Empire. Infez Med. 2009, 17 (4): 261-275.PubMedGoogle Scholar
  4. Conlon JM: The historical impact of epidemic typhus. http://entomology.montana.edu/historybug/typhus-conlon.pdf. Last accessed 29 Jun 2014
  5. Kunwar R, Singh H, Mangla V, Hiremath R: Outbreak investigation: salmonella food poisoning. Med J Armed Forces India. 2013, 69 (4): 388-391. 10.1016/j.mjafi.2013.01.005.PubMed CentralPubMedGoogle Scholar
  6. Nichol M: Queen’s guards invaded… by a scabies outbreak: military exercises in Germany blamed as dozens are hit by skin disease. http://www.dailymail.co.uk/news/article-2305038/Queens-Guards-invaded--scabies-outbreak-Military-exercises-Germany-blamed-dozens-hit-skin-disease.html. Last accessed 30 Jun 2014
  7. Kasper MR, Lescano AG, Lucas C, Gilles D, Biese BJ, Stolovitz G, Reaves EJ: Diarrhea outbreak during U.S. military training in El Salvador. PLoS One. 2012, 7 (7): e40404-10.1371/journal.pone.0040404.PubMed CentralPubMedGoogle Scholar
  8. Hart TA, Hardenbergh WH: The southwest pacific area. Preventive medicine in world War II, volume VI: communicable diseases: malaria. Chapter 10. http://history.amedd.army.mil/booksdocs/wwii/Malaria/tables/table 79.pdf. (Last accessed 15 Apr 14)
  9. Beadle C, Hoffman SL: History of malaria in the United States naval forces at war: World War I through the Vietnam conflict. Clin Infect Dis. 1993, 16 (2): 320-329. 10.1093/clind/16.2.320.PubMedGoogle Scholar
  10. Smallman-Raynor MR, Cliff AD: Impact of infectious diseases on war. Infect Dis Clin North Am. 2004, 18 (2): 341-368. 10.1016/j.idc.2004.01.009.PubMedGoogle Scholar
  11. Korzeniewski K, Nitsch-Osuch A, Chciałowski A, Korsak J: Environmental factors, immune changes and respiratory diseases in troops during military activities. Respir Physiol Neurobiol. 2013, 187 (1): 118-122. 10.1016/j.resp.2013.02.003.PubMedGoogle Scholar
  12. Arness MK, Feighner BH, Canham ML, Taylor DN, Monroe SS, Cieslak TJ, Hoedebecke EL, Polyak CS, Cuthie JC, Fankhauser RL, Humphrey CD, Barker TL, Jenkins CD, Skillman DR: Norwalk-like viral gastroenteritis outbreak in U.S. Army trainees. Emerg Infect Dis. 2000, 6 (2): 204-207. 10.3201/eid0602.009918.PubMed CentralPubMedGoogle Scholar
  13. Grotto I, Huerta M, Balicer RD, Halperin T, Cohen D, Orr N, Gdalevich M: An outbreak of norovirus gastroenteritis on an Israeli military base. Infection. 2004, 32 (6): 339-343. 10.1007/s15010-004-4002-3.PubMedGoogle Scholar
  14. Yap J, Qadir A, Liu I, Loh J, Tan BH, Lee VJ: Outbreak of acute norovirus gastroenteritis in a military facility in Singapore: a public health perspective. Singapore Med J. 2012, 53 (4): 249-254.PubMedGoogle Scholar
  15. Summers JA: Pandemic influenza outbreak on a troop ship–diary of a soldier in 1918. Emerg Infect Dis. 2012, 18 (11): 1900-1903. 10.3201/eid1811.AD1811.PubMed CentralPubMedGoogle Scholar
  16. Jeger V, Dünki A, Germann M, Fux CA, Faas A, Exadaktylos AK, Stettbacher A: H1N1 outbreak in a Swiss military boot camp–observations and suggestions. Swiss Med Wkly. 2011, 141: w13307-PubMedGoogle Scholar
  17. Cosby MT, Pimentel G, Nevin RL, Fouad Ahmed S, Klena JD, Amir E, Younan M, Browning R, Sebeny PJ: Outbreak of H3N2 influenza at a US military base in Djibouti during the H1N1 pandemic of 2009. PLoS One. 2013, 8 (12): e82089-10.1371/journal.pone.0082089.PubMed CentralPubMedGoogle Scholar
  18. Majeed A, Naeem Z, Khan DA, Ayaz A: Epidemic adenoviral conjunctivitis report of an outbreak in a military garrison and recommendations for its management and prevention. J Pak Med Assoc. 2005, 55 (7): 273-275.PubMedGoogle Scholar
  19. Paparello SF, Rickman LS, Mesbahi HN, Ward JB, Siojo LG, Hayes CG: Epidemic keratoconjunctivitis at a U.S. military base: Republic of the Philippines. Mil Med. 1991, 156 (5): 256-259.PubMedGoogle Scholar
  20. Crum NF, Barrozo CP, Chapman FA, Ryan MA, Russell KL: An outbreak of conjunctivitis due to a novel unencapsulated streptococcus pneumoniae among military trainees. Clin Infect Dis. 2004, 39 (8): 1148-1154. 10.1086/424522.PubMedGoogle Scholar
  21. White DW, Feigley CE, McKeown RE, Hout JJ, Hebert JR: Association between barracks type and acute respiratory infection in a gender integrated Army basic combat training population. Mil Med. 2011, 176 (8): 909-914. 10.7205/MILMED-D-10-00418.PubMed CentralPubMedGoogle Scholar
  22. Benenson MW, Takafuji ET, Bancroft WH, Lemon SM, Callahan MC, Leach DA: A military community outbreak of hepatitis type a related to transmission in a child care facility. Am J Epidemiol. 1980, 112 (4): 471-481.PubMedGoogle Scholar
  23. Centers for Disease Control and Prevention (CDC): Acute respiratory disease associated with adenovirus serotype 14--four states, 2006–2007. MMWR Morb Mortal Wkly Rep. 2007, 56 (45): 1181-1184.Google Scholar
  24. Ong AE, Dashraath P, Lee VJ: Management of enteroviral conjunctivitis outbreaks in the Singapore military in 2005. Southeast Asian J Trop Med Public Health. 2008, 39 (3): 398-403.PubMedGoogle Scholar
  25. Mossong J, Bonert C, Weicherding P, Opp M, Reichert P, Even J, Schneider F: Mumps outbreak among the military in Luxembourg in 2008: epidemiology and evaluation of control measures. Euro Surveill. 2009, 14 (7):Google Scholar
  26. Chretien JP, Blazes DL, Coldren RL, Lewis MD, Gaywee J, Kana K, Sirisopana N, Vallejos V, Mundaca CC, Montano S, Martin GJ, Gaydos JC: The importance of militaries from developing countries in global infectious disease surveillance. Bull World Health Organ. 2007, 85 (3): 174-180. 10.2471/BLT.06.037101.PubMed CentralPubMedGoogle Scholar
  27. Bailey MS, Gallimore CI, Lines LD, Green AD, Lopman BA, Gray JJ, Brown DW: Viral gastroenteritis outbreaks in deployed British troops during 2002–7. J R Army Med Corps. 2008, 154 (3): 156-159. 10.1136/jramc-154-03-04.PubMedGoogle Scholar
  28. Kitchener S, Leggat PA, Brennan L, McCall B: Importation of dengue by soldiers returning from east Timor to north Queensland, Australia. J Travel Med. 2002, 9 (4): 180-183.PubMedGoogle Scholar
  29. Ciminera P, Brundage J: Malaria in U.S. Military forces: a description of deployment exposures from 2003 through 2005. Am J Trop Med Hyg. 2007, 76 (2): 275-279.PubMedGoogle Scholar
  30. D’Amelio R, Molica C, Biselli R, Stroffolini T: Surveillance of infectious diseases in the Italian military as pre-requisite for tailored vaccination programme. Vaccine. 2001, 19 (15–16): 2006-2011.PubMedGoogle Scholar
  31. Seah SG, Lim EA, Kok-Yong S, Liaw JC, Lee V, Kammerer P, Metzgar D, Russell KL, Tan BH: Viral agents responsible for febrile respiratory illnesses among military recruits training in tropical Singapore. J Clin Virol. 2010, 47 (3): 289-292. 10.1016/j.jcv.2009.12.011.PubMedGoogle Scholar
  32. Tan XQ, Zhao X, Lee VJ, Loh JP, Tan BH, Koh WH, Ng SH, Chen MI, Cook AR: Respiratory viral pathogens among Singapore military servicemen 2009–2012: epidemiology and clinical characteristics. BMC Infect Dis. 2014, 14 (1): 204-10.1186/1471-2334-14-204.PubMed CentralPubMedGoogle Scholar
  33. Gambel JM, Drabick JJ, Martinez-Lopez L: Medical surveillance of multinational peacekeepers deployed in support of the United Nations mission in Haiti, June-October 1995. Int J Epidemiol. 1999, 28 (2): 312-318. 10.1093/ije/28.2.312.PubMedGoogle Scholar
  34. Kana K, Tabprasit S, Chuenchitra T, Sirisopana N, Rangsin R: HIV-1 incidence estimates among young Thai men using IgG-capture BED-enzyme immunoassay (BED-CEIA) during 2005–2006. J Med Assoc Thai. 2009, 92 (Suppl 1): S112-S116.PubMedGoogle Scholar
  35. Kiliç S, Gray GC: Nonpharmaceutical interventions for military populations during pandemic influenza. Turk Silahli Kuvvetleri Koruyucu Hekim Bul. 2007, 6 (4): 285-290.PubMed CentralPubMedGoogle Scholar
  36. Lee V, Yap J, Cook AR, Chen M, Tay J, Barr I, Kelso A, Tan B, Loh JP, Lin R, Cui L, Kelly PM, Leo Y, Chia K, Kang WL, Tambyah P, Seet B: Effectiveness of public health measures in mitigating pandemic influenza spread: a prospective sero-epidemiological cohort study. J Infect Dis. 2010, 202 (9): 1319-1326. 10.1086/656480.PubMedGoogle Scholar
  37. Yeo DS, Seah SG, Chew JS, Lim EA, Liaw JC, Loh JP, Tan BH: Molecular Identification of coxackievirus A24 variant isolated from an outbreak of acute haemorrhagic conjunctivitis in Singapore in 2005. Arch Virol. 2007, 152 (11): 2005-2016. 10.1007/s00705-007-1032-z.PubMedGoogle Scholar
  38. Hospenthal DR, Green AD, Crouch HK, English JF, Pool J, Yun HC, Murray CK, Prevention of Combat-Related Infections Guidelines Panel: Infection prevention and control in deployed military medical treatment facilities. J Trauma. 2011, 71 (2 Suppl 2): S290-S298.PubMedGoogle Scholar
  39. Keen EF, Mende K, Yun HC, Aldous WK, Wallum TE, Guymon CH, Cole DW, Crouch HK, Griffith ME, Thompson BL, Rose JT, Murray CK: Evaluation of potential environmental contamination sources for the presence of multidrug-resistant bacteria linked to wound infections in combat casualties. Infect Control Hosp Epidemiol. 2012, 33 (9): 905-911. 10.1086/667382.PubMedGoogle Scholar
  40. Crouch HK, Murray CK, Hospenthal DR: Development of a deployment infection control course. Mil Med. 2010, 175 (12): 983-989. 10.7205/MILMED-D-10-00164.PubMedGoogle Scholar
  41. Grabenstein JD, Pittman PR, Greenwood JT, Engler RJ: Immunization to protect the US armed forces: heritage, current practice, and prospects. Epidemiol Rev. 2006, 28: 3-26. 10.1093/epirev/mxj003.PubMedGoogle Scholar
  42. U.S. Military and vaccine history.http://history.amedd.army.mil/booksdocs/wwii/Malaria/tables/table79.pdf,
  43. Schmaljohn CS, Smith LA, Friedlander AM: Military vaccines in today’s environment. Hum Vaccin Immunother. 2012, 8 (8): 1126-1128. 10.4161/hv.20503.PubMed CentralPubMedGoogle Scholar
  44. Artenstein AW: Vaccines for military use. Vaccine. 2009, 27 (Suppl 4): D16-D22.PubMedGoogle Scholar
  45. Mimouni D, Bar-Zeev Y, Huerta M, Balicer RD, Grotto I, Ankol O: Preventive effect of meningococcal vaccination in Israeli military recruits. Am J Infect Control. 2010, 38 (1): 56-58. 10.1016/j.ajic.2009.04.290.PubMedGoogle Scholar
  46. Kuschner RA, Russell KL, Abuja M, Bauer KM, Faix DJ, Hait H, Henrick J, Jacobs M, Liss A, Lynch JA, Liu Q, Lyons AG, Malik M, Moon JE, Stubbs J, Sun W, Tang D, Towle AC, Walsh DS, Wilkerson D, Adenovirus Vaccine Efficacy Trial Consortium: A phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of the live, oral adenovirus type 4 and type 7 vaccine, in U.S. military recruits. Vaccine. 2013, 31 (28): 2963-2971. 10.1016/j.vaccine.2013.04.035.PubMedGoogle Scholar
  47. Headquarters, Departments of the Army, the Navy, the Air Force, and the Coast Guard: Army regulation 40–562. Immunizations and chemoprophylaxis for the prevention of infectious diseases. 2013,http://www.apd.army.mil/pdffiles/r40_562.pdf,Google Scholar
  48. D’Amelio R, Heymann DL: Can the military contribute to global surveillance and control of infectious diseases?. Emerg Infect Dis. 1998, 4 (4): 704-705. 10.3201/eid0404.980429.PubMed CentralPubMedGoogle Scholar
  49. Mancuso JD, Tobler SK, Eick AA, Keep LW: Active tuberculosis and recent overseas deployment in the U.S. military. Am J Prev Med. 2010, 39 (2): 157-163. 10.1016/j.amepre.2010.03.017.PubMedGoogle Scholar
  50. Haller JS: Trench foot–a study in military-medical responsiveness in the Great War, 1914–1918. West J Med. 1990, 152 (6): 729-733.PubMed CentralPubMedGoogle Scholar
  51. Wainwright M: Hitler’s penicillin. Perspect Biol Med. 2004, 47 (2): 189-198. 10.1353/pbm.2004.0037. SpringPubMedGoogle Scholar
  52. Kitchen LW, Vaughn DW, Skillman DR: Role of US military research programs in the development of US food and drug administration–approved antimalarial drugs. Clin Infect Dis. 2006, 43 (1): 67-71. 10.1086/504873.PubMedGoogle Scholar
  53. Lee VJ, Yap J, Cook AR, Chen MI, Tay JK, Tan BH, Loh JP, Chew SW, Koh WH, Lin R, Cui L, Lee CW, Sung WK, Wong CW, Hibberd ML, Kang WL, Seet B, Tambyah PA: Oseltamivir ring prophylaxis for containment of 2009 H1N1 influenza outbreaks. N Engl J Med. 2010, 362 (23): 2166-2174. 10.1056/NEJMoa0908482. doi: 10.1056/NEJMoa0908482PubMedGoogle Scholar
  54. Armstrong AW, Ulukan S, Weiner M, Mostafa M, Shaheen H, Nakhla I, Tribble DR, Riddle MS: A randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of rifaximin for the prevention of travelers’ diarrhea in US military personnel deployed to incirlik air base, incirlik, turkey. J Travel Med. 2010, 17 (6): 392-394. 10.1111/j.1708-8305.2010.00462.x.PubMedGoogle Scholar
  55. Lewandowski L, Purcell R, Fleming M, Gordon WT: The use of dilute Dakin’s solution for the treatment of angioinvasive fungal infection in the combat wounded: a case series. Mil Med. 2013, 178 (4): e503-e507. 10.7205/MILMED-D-12-00322.PubMedGoogle Scholar
  56. Lee SO: Commencement of the meningococcal vaccination for the republic of Korea army. Infect Chemother. 2013, 45 (1): 113-115. 10.3947/ic.2013.45.1.113.PubMed CentralPubMedGoogle Scholar
  57. Lee VJ, Ow S, Heah H, Tan MY, Lam P, Ng LC, Lam-Phua SG, Imran AQ, Seet B: Elimination of malaria risk through integrated combination strategies in a tropical military training island. Am J Trop Med Hyg. 2010, 82 (6): 1024-1029. 10.4269/ajtmh.2010.09-0562.PubMed CentralPubMedGoogle Scholar
  58. Johns MC1, Burke RL, Vest KG, Fukuda M, Pavlin JA, Shrestha SK, Schnabel DC, Tobias S, Tjaden JA, Montgomery JM, Faix DJ, Duffy MR, Cooper MJ, Sanchez JL, Blazes DL, Wangchuk S, Dorji T, Gibbons R, Iamsirithaworn S, Richardson J, Buathong R, Jarman R, Yoon IK, Shakya G, Ofula V, Coldren R, Bulimo W, Sang R, Omariba D, AFHSC-GEIS Outbreak Response Writing Group, et al:A growing global network's role in outbreak response: AFHSC-GEIS 2008–2009. BMC Public Health. 2011, 11 (Suppl 2): S3-10.1186/1471-2458-11-S2-S3.PubMed CentralPubMedGoogle Scholar
  59. Auerbach PS, Norris RL, Menon AS, Brown IP, Kuah S, Schwieger J, Kinyon J, Helderman TN, Lawry L: Civil-military collaboration in the initial medical response to the earthquake in Haiti. N Engl J Med. 2010, 362 (10): e32-10.1056/NEJMp1001555.PubMedGoogle Scholar
  60. UN News Centre: UN updates guidelines for international military aid in disaster relief operations. Published 27 November 2006. http://www.un.org/apps/news/story.asp?NewsID=20733#.VDCeqfmSzuJ?=?20733#. Last accessed 13 July 2014
  61. United Nations Office for the Coordination of Humanitarian Affairs: Oslo guidelines: guidelines on the Use of foreign military and civil defence assets in disaster relief. Revision 1.1 November 2007. http://www.refworld.org/pdfid/47da87822.pdf
  62. Hasegawa GR: Quinine substitutes in the confederate army. Mil Med. 2007, 172 (6): 650-655.PubMedGoogle Scholar
  63. Ott M, Shaw SF, Danila RN, Lynfield R: Lessons learned from the 1918–1919 influenza pandemic in Minneapolis and St. Paul, Minnesota. Public Health Rep. 2007, 122 (6): 803-810.PubMed CentralPubMedGoogle Scholar
  64. Wever PC, van Bergen L: Prevention of tetanus during the First World War. Med Humanit. 2012, 38 (2): 78-82. 10.1136/medhum-2011-010157.PubMedGoogle Scholar
  65. Hirsch EF: “The treatment of infected wounds”, Alexis Carrel’s contribution to the care of wounded soldiers during world War 1. J Trauma. 2008, 64 (3 Suppl): S209-S210.PubMedGoogle Scholar
  66. Shama G: Auntibiotics: the BBC, penicillin, and the second world war. BMJ. 2008, 337: a2746-10.1136/bmj.a2746.PubMedGoogle Scholar
  67. Bavaro MF, Kelly DJ, Dasch GA, Hale BR, Olson P: History of U.S. Military contributions to the study of rickettsial diseases. Mil Med. 2005, 170 (4 Suppl): 49-60.PubMedGoogle Scholar
  68. Weina PJ: From atabrine in World War II to mefloquine in Somalia: the role of education in preventive medicine. Mil Med. 1998, 163 (9): 635-639.PubMedGoogle Scholar
  69. Leggat PA, Melrose W: Lymphatic filariasis: disease outbreaks in military deployments from World War II. Mil Med. 2005, 170 (7): 585-589.PubMedGoogle Scholar
  70. Marshall RC, Rhodes CB: Korean hemorrhagic fever: environmental health and medical surveillance measures. Mil Med. 1990, 155 (12): 607-610.PubMedGoogle Scholar
  71. Gibbons RV, Streitz M, Babina T, Fried JR: Dengue and US military operations from the Spanish-American War through today. Emerg Infect Dis. 2012, 18 (4): 623-630.PubMed CentralPubMedGoogle Scholar
  72. Marshall JD, Joy RJ, Ai NV, Quy DV, Stockard JL, Gibson FL: Plague in Vietnam 1965–1966. Am J Epidemiol. 1967, 86 (2): 603-616.PubMedGoogle Scholar
  73. Hyams KC, Riddle J, Trump DH, Graham JT: Endemic infectious diseases and biological warfare during the Gulf War: a decade of analysis and final concerns. Am J Trop Med Hyg. 2001, 65 (5): 664-670.PubMedGoogle Scholar
  74. Wallace MR, Sharp TW, Smoak B, Iriye C, Rozmajzl P, Thornton SA, Batchelor R, Magill AJ, Lobel HO, Longer CF, Burans JP: Malaria among United States troops in Somalia. Am J Med. 1996, 100 (1): 49-55. 10.1016/S0002-9343(96)90011-X.PubMedGoogle Scholar
  75. Zapor MJ, Moran KA: Infectious diseases during wartime. Curr Opin Infect Dis. 2005, 18 (5): 395-399. 10.1097/01.qco.0000182102.50430.2c.PubMedGoogle Scholar
  76. Coleman RE, Hochberg LP, Putnam JL, Swanson KI, Lee JS, McAvin JC, Chan AS, Oguinn ML, Ryan JR, Wirtz RA, Moulton JK, Dave K, Faulde MK: Use of vector diagnostics during military deployments: recent experience in Iraq and Afghanistan. Mil Med. 2009, 174 (9): 904-920. 10.7205/MILMED-D-00-2509.PubMedGoogle Scholar
  77. Aronson NE, Sanders JW, Moran KA: In harm’s way: infections in deployed American military forces. Clin Infect Dis. 2006, 43 (8): 1045-1051. 10.1086/507539. Epub 2006 Sep 14PubMedGoogle Scholar
  78. Thornton SA, Sherman SS, Farkas T, Zhong W, Torres P, Jiang X: Gastroenteritis in US marines during operation Iraqi freedom. Gastroenteritis in US marines during operation Iraqi freedom. Clin Infect Dis. 2005, 40 (4): 519-525. 10.1086/427501.PubMedGoogle Scholar
  79. Centers for Disease Control and Prevention (CDC): Outbreak of acute gastroenteritis associated with Norwalk-like viruses among British military personnel--Afghanistan, May 2002. MMWR Morb Mortal Wkly Rep. 2002, 51 (22): 477-479.Google Scholar
  80. Hospenthal DR, Crouch HK, English JF, Leach F, Pool J, Conger NG, Whitman TJ, Wortmann GW, Murray CK, Cordts PR, Gamble WB: Response to infection control challenges in the deployed setting: operations Iraqi and enduring freedom. J Trauma. 2010, 69 (Suppl 1): S94-S101.PubMedGoogle Scholar
  81. McCarthy M, Estes MK, Hyams KC: Norwalk-like virus infection in military forces: epidemic potential, sporadic disease, and the future direction of prevention and control efforts. J Infect Dis. 2000, 181 (Suppl 2): S387-S391.PubMedGoogle Scholar
  82. Trofa AF, DeFraites RF, Smoak BL, Kanesa-thasan N, King AD, Burrous JM, MacArthy PO, Rossi C, Hoke CH: Dengue fever in US military personnel in Haiti. JAMA. 1997, 277 (19): 1546-1548. 10.1001/jama.1997.03540430058033.PubMedGoogle Scholar
  83. Sharp TW, Wallace MR, Hayes CG, Sanchez JL, DeFraites RF, Arthur RR, Thornton SA, Batchelor RA, Rozmajzl PJ, Hanson RK, Wu SJ, Iriye C, Burans JP: Dengue fever in U.S. Troops during operation restore hope, Somalia, 1992–1993. Am J Trop Med Hyg. 1995, 53 (1): 89-94.PubMedGoogle Scholar
  84. Croft AM, Ollerton JE, Fear NT: Hepatitis B infection following deployment to Angola. J R Nav Med Serv. 2008, 94 (3): 108-111.PubMedGoogle Scholar
  85. Myint KS, Duripunt P, Mammen MP, Sirisopana N, Rodkvamtook W, Gibbons RV: Hepatitis E virus infection in Thai troops deployed with U.N. peacekeeping forces. Mil Med. 2007, 172 (11): 1217-1219.PubMedGoogle Scholar
  86. Riddle MS, Halvorson HA, Shiau D, Althoff J, Monteville MR, Shaheen H, Horvath EP, Armstrong AW: Acute gastrointestinal infection, respiratory illness, and noncombat injury among US military personnel during operation bright star 2005, in northern Egypt. J Travel Med. 2007, 14 (6): 392-401. 10.1111/j.1708-8305.2007.00159.x.PubMedGoogle Scholar
  87. Newton JA, Schnepf GA, Wallace MR, Lobel HO, Kennedy CA, Oldfield EC: Malaria in US marines returning from Somalia. JAMA. 1994, 272 (5): 397-399. 10.1001/jama.1994.03520050077034.PubMedGoogle Scholar
  88. Trunkey DD: History and development of trauma care in the United States. Clin Orthop Relat Res. 2000, 374: 36-46.PubMedGoogle Scholar
  89. Brodie B: The search for penicillin. Windows Time. 2004, 12 (2): 6-11.PubMedGoogle Scholar
  90. Centers for Disease Control and Prevention (CDC): Imported human rabies in a U.S. Army soldier - New York, 2011. MMWR Morb Mortal Wkly Rep. 2012, 61 (17): 302-305.Google Scholar
  91. Faix DJ, Harrison DJ, Riddle MS, Vaughn AF, Yingst SL, Earhart K, Thibault G: Outbreak of Q fever among US military in western Iraq, June-July 2005. Clin Infect Dis. 2008, 46 (7): e65-e68. 10.1086/528866.PubMedGoogle Scholar
  92. Trei JS, Johns NM, Garner JL, Noel LB, Ortman BV, Ensz KL, Johns MC, Bunning ML, Gaydos JC: Spread of adenovirus to geographically dispersed military installations, May-October 2007. Emerg Infect Dis. 2010, 16 (5): 769-775. 10.3201/eid1605.091633.PubMed CentralPubMedGoogle Scholar
  93. Ali R, Mounts AW, Parashar UD, Sahani M, Lye MS, Isa MM, Balathevan K, Arif MT, Ksiazek TG: Nipah virus among military personnel involved in pig culling during an outbreak of encephalitis in Malaysia, 1998–1999. Emerg Infect Dis. 2001, 7 (4): 759-761. 10.3201/eid0704.017432.PubMed CentralPubMedGoogle Scholar
  94. Mayet A, Manet G, Decam C, Morisson D, Bédubourg G, Pommier De Santi V, Meynard JB, Bornert G, Deparis X, Migliani R: Epidemiology of food-borne disease outbreaks in the French armed forces: a review of investigations conducted from 1999 to 2009. J Infect. 2011, 63 (5): 370-374. 10.1016/j.jinf.2011.08.003.PubMedGoogle Scholar
  95. Schwaber MJ, Grotto I, Balicer RD, Davidovitch N, Zelikovitch Y, Huerta M: Infectious diarrheal outbreaks in the Israeli military, 1988–2002. Mil Med. 2005, 170 (7): 634-637.PubMedGoogle Scholar
  96. Wilder-Smith A: Tsunami in South Asia: what is the risk of post-disaster infectious disease outbreaks?. Ann Acad Med Singapore. 2005, 34 (10): 625-631.PubMedGoogle Scholar
  97. Chen MI, Lee VJ, Lim WY, Barr IG, Lin RT, Koh GC, Yap J, Cui L, Cook AR, Laurie K, Tan LW, Tan BH, Loh J, Shaw R, Durrant C, Chow VT, Kelso A, Chia KS, Leo YS: 2009 influenza A(H1N1) seroconversion rates and risk factors among distinct adult cohorts in Singapore. JAMA. 2010, 303 (14): 1383-1391. 10.1001/jama.2010.404.PubMedGoogle Scholar
  98. World Health Organisation: Report of the WHO informal consultation on dual Use research of concern. 2013Google Scholar
  99. Riedel S: Biological warfare and bioterrorism: a historical review. Proc (Bayl Univ Med Cent). 2004, 17 (4): 400-406.Google Scholar
  100. Metcalfe N: A short history of biological warfare. Med Confl Surviv. 2002, 18 (3): 271-282. 10.1080/13623690208409635.PubMedGoogle Scholar
  101. Jacobs MK: The history of biologic warfare and bioterrorism. Dermatol Clin. 2004, 22 (3): 231-246. 10.1016/j.det.2004.03.008.PubMedGoogle Scholar
  102. Danzig R, Sageman M, Leighton T, Hough L, Yuki H, Kotani R, Hosford ZM: Aum shinrikyo: insights into how terrorists develop biological and chemical weapons. 2011, Centre for a New American SecurityGoogle Scholar
  103. Jernigan JA, Stephens DS, Ashford DA, Omenaca C, Topiel MS, Galbraith M, Tapper M, Fisk TL, Zaki S, Popovic T, Meyer RF, Quinn CP, Harper SA, Fridkin SK, Sejvar JJ, Shepard CW, McConnell M, Guarner J, Shieh WJ, Malecki JM, Gerberding JL, Hughes JM, Perkins BA, Anthrax Bioterrorism Investigation Team: Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis. 2001, 7 (6): 933-944. 10.3201/eid0706.010604.PubMed CentralPubMedGoogle Scholar
  104. Zhang Y, Lopez-Gatell H, Alpuche-Aranda CM, Stoto MA: Did advances in global surveillance and notification systems make a difference in the 2009 H1N1 pandemic?–a retrospective analysis. PLoS One. 2013, 8 (4): e59893-10.1371/journal.pone.0059893.PubMed CentralPubMedGoogle Scholar
  105. Duron S, Mayet A, Lienhard F, Haus-Cheymol R, Verret C, Védy S, Le Guen P, Berbineau L, Brisou P, Dubrous P, Garnotel E, Meynard JB, Deparis X, Mérens A, Bigaillon C, Migliani R, MISS staff: The French Military influenza surveillance system (MISS): overview of epidemiological and virological results during four influenza seasons–2008–2012. Swiss Med Wkly. 2013, 143: w13848-PubMedGoogle Scholar

Copyright

© Ho et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.